Cost‐effectiveness of scaling‐up HCV prevention and treatment in the United States for people who inject drugs-Reference-Cited by-同舟云学术

Cost‐effectiveness of scaling‐up HCV prevention and treatment in the United States for people who inject drugs

Published:2019-08-02 Issue:12 Volume:114 Page:2267-2278
ISSN:0965-2140
Container-title:Addiction
language:en
Short-container-title:Addiction

Author:

Barbosa Carolina¹^ORCID,Fraser Hannah²^ORCID,Hoerger Thomas J.¹,Leib Alyssa³,Havens Jennifer R.⁴,Young April⁴^ORCID,Kral Alex¹,Page Kimberly⁵^ORCID,Evans Jennifer⁶,Zibbell Jon¹,Hariri Susan⁷,Vellozzi Claudia⁸,Nerlander Lina⁷^ORCID,Ward John W.⁷,Vickerman Peter²^ORCID

Affiliation:

1. RTI International, Research Triangle Park NC USA

2. University of Bristol Bristol UK

3. Department of Chemistry University of Colorado Denver USA

4. College of Medicine University of Kentucky Lexington KY USA

5. Health Sciences Center University of New Mexico Albuquerque NM USA

6. Univerisity of California San Francisco CA USA

7. Centers for Disease Control and Prevention Atlanta GA USA

8. Grady Health System Atlanta GA USA

Funder

Centers for Disease Control and Prevention

Publisher

Wiley

Subject

Psychiatry and Mental health,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/add.14731

Reference85 articles.

1. Toward a more accurate estimate of the prevalence of hepatitis C in the United States

2. Centers for Disease Control and Prevention. Viral Hepatitis Surveillance United States 2015. Available at:https://www.cdc.gov/hepatitis/statistics/2015surveillance/pdfs/2015HepSurveillanceRpt.pdf(accessed 16 May 2019) (Archived at:http://www.webcitation.org/78PtzMtMGon 16 May 2019).

3. Chronic hepatitis C virus (HCV) disease burden and cost in the United States

4. Centers for Disease Control and Prevention. Surveillance for Viral Hepatitis—United States 2013. Available at:http://www.cdc.gov/hepatitis/statistics/2013surveillance/index.htm(accessed 16 May 2019) (Archived athttp://www.webcitation.org/78Q7FBGbton 16 May 2019).

5. Individual and Network Factors Associated With Prevalent Hepatitis C Infection Among Rural Appalachian Injection Drug Users

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Illicit Fentanyl Use and Hepatitis C Virus Seroconversion Among People Who Inject Drugs in Tijuana and San Diego: Results From a Binational Cohort Study;Clinical Infectious Diseases;2024-07-30

2. Cost effectiveness of hepatitis C direct acting agents;Expert Review of Pharmacoeconomics & Outcomes Research;2024-05-03

3. Illicit Fentanyl Use Independently Predicts HCV Seroconversion Among a Cohort of People Who Inject Drugs in Tijuana and San Diego;2024-03-24

4. Real‐world hepatitis C prevalence and treatment uptake at opioid agonist therapy clinics in Ontario, Canada;Journal of Viral Hepatitis;2024-02-22